Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tarsus Pharmaceuticals, Inc.

NASDAQ: TARS · Life Sciences · 3 alerts · CIK 1819790

Share price
$78.68Close, Nov 16
Market cap
$3.88B
Shares outstanding
49.31MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tarsus Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:09 PM ET 10-Q
Financial Results

Tarsus Pharmaceuticals Q3 2026 Results: Net Loss of $668M, Loss Widens

Tarsus Pharmaceuticals reported a significant net loss of $693.9 million for the nine months ended September 30, 2026, primarily driven by $632.2 million in acquired in-process research and development expenses from the acquisitions of iRenix and Alkeus. Despite the net loss, total revenues grew to $530.5 million, up from $299.7 million in the prior year, fueled by strong product sales.

Key figure
Net loss $668M
4:07 PM ET 8-K
Financial Results

Tarsus Pharmaceuticals Financial Results

Tarsus Pharmaceuticals reported record third quarter 2026 financial results, highlighted by XDEMVY net product sales of $194.6 million, a 64% year-over-year increase. The company surpassed one million bottles dispensed and $1 billion in cumulative net sales since the product's launch, while also announcing the appointment of Neera Clase as Chief Commercial Officer.

“XDEMVY has shown what that focus can achieve. In just three years since launch, we have dispensed more than one million bottles and generated $1 billion in cumulative net product sales, and with continued robust growth, we are only getting started. That strength is helping us build one of the most differentiated pipelines in eye care, with the potential to bring five medicines to patients in the next five years.”

Bobby Azamian, M.D., Ph.D., Chief Executive Officer and Chairman of Tarsus

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.